(Q30578166)

25 June 2017

1 reference

Meta-analysis of clinical trial safety data in a drug development program: answers to frequently asked questions (English)

1 reference

25 June 2017

1 reference

Jesse A Berlin

1

1 reference

25 June 2017

Brenda J Crowe

2

1 reference

25 June 2017

Edward Whalen

3

1 reference

25 June 2017

H Amy Xia

4

1 reference

25 June 2017

Carol E Koro

5

1 reference

25 June 2017

Juergen Kuebler

6

1 reference

25 June 2017

publication date

21 November 2012

1 reference

25 June 2017

1 reference

25 June 2017

volume

10

1 reference

25 June 2017

issue

1

1 reference

25 June 2017

page(s)

20-31

1 reference

Effect of Rosiglitazone on the Risk of Myocardial Infarction and Death from Cardiovascular Causes

25 June 2017

cites work

1 reference

https://api.crossref.org/works/10.1177%2F1740774512465495

Clinical response and risk for reported suicidal ideation and suicide attempts in pediatric antidepressant treatment: a meta-analysis of randomized controlled trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1740774512465495

Suicidality in pediatric patients treated with antidepressant drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1740774512465495

Recommendations for safety planning, data collection, evaluation and reporting during drug, biologic and vaccine development: a report of the safety planning, evaluation, and reporting team

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1740774512465495

Bayesian meta-experimental design: evaluating cardiovascular risk in new antidiabetic therapies to treat type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1740774512465495

Secondary use of randomized controlled trials to evaluate drug safety: a review of methodological considerations

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1740774512465495

Cardiovascular safety of non-steroidal anti-inflammatory drugs: network meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1740774512465495

Validity of indirect comparisons in meta-analysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1740774512465495

Indirect comparisons: the mesh and mess of clinical trials.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1740774512465495

Comparison of meta-analysis versus analysis of variance of individual patient data

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1740774512465495

Columbia Classification Algorithm of Suicide Assessment (C-CASA): classification of suicidal events in the FDA's pediatric suicidal risk analysis of antidepressants

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1740774512465495

The effect of antilymphocyte induction therapy on renal allograft survival. A meta-analysis of individual patient-level data. Anti-Lymphocyte Antibody Induction Therapy Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1740774512465495

Individual patient- versus group-level data meta-regressions for the investigation of treatment effect modifiers: ecological bias rears its ugly head

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1740774512465495

A comparison of summary patient-level covariates in meta-regression with individual patient data meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1740774512465495

Meta-regression detected associations between heterogeneous treatment effects and study-level, but not patient-level, factors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1740774512465495

Bayesian hierarchical modeling for detecting safety signals in clinical trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1740774512465495

Why sources of heterogeneity in meta-analysis should be investigated

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1740774512465495

A basic introduction to fixed-effect and random-effects models for meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1740774512465495

Heterogeneity and statistical significance in meta-analysis: an empirical study of 125 meta-analyses

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1740774512465495

Relative risks and confidence intervals were easily computed indirectly from multivariable logistic regression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1740774512465495

What to add to nothing? Use and avoidance of continuity corrections in meta-analysis of sparse data

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1740774512465495

Random-effects meta-analyses are not always conservative.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1740774512465495

Bayesian measures of model complexity and fit

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1740774512465495

21 January 2018

Identifiers

DOI

10.1177/1740774512465495

1 reference

25 June 2017

1 reference